Parameter
|
Value
|
Unit
|
Reference value
|
Parameter
|
Value
|
Unit
|
Reference value
|
Parameter
|
Value
|
Unit
|
Reference value
|
---|
Blood cell count
|
Biochemistry
|
Immunology
|
WBC
|
4720
|
× 103/μL
| |
TP
|
9.0
|
mg/dL
|
6.5–8.2
|
CRP
|
0.79
|
mg/dL
|
< 0.30
|
St
|
0
|
%
|
0.0–19.0
|
Alb
|
3.6
|
mg/dL
|
3.7–5.5
|
IgG
|
2532
|
mg/dL
|
820–1740
|
Seg
|
89
|
%
|
27.0–72.0
|
α1
|
3.6
|
%
|
1.7–2.9
|
IgA
|
457
|
mg/dL
|
90–4000
|
Ly
|
6
|
%
|
18.0–50.0
|
α2
|
10.5
|
%
|
5.7–9.5
|
IgM
|
96
|
mg/dL
|
31–200
|
Mo
|
5
|
%
|
1.0–8.0
|
β
|
10.0
|
%
|
7.2–11.1
|
HBsAb
|
(−)
| |
(−)
|
Eo
|
0
|
%
|
0.0–7.0
|
γ
|
29.5
|
%
|
10.2–20.4
|
HBcAb
|
(−)
| |
(−)
|
Ba
|
0
|
%
|
0.0–2.0
|
BUN
|
13
|
mg/ dl
|
8.0–20.0
|
HBV-DNA
|
(−)
| |
(−)
|
RBC
|
5
|
×106/μL
|
4.38–5.77
|
Cre
|
1
|
mg/ dl
|
0.65–1.09
|
HCV Ab
|
(+)
| |
(−)
|
Hb
|
15
|
g/dL
|
13.6–18.3
|
T-bil
|
0.4
|
mg/dL
|
0.3–1.2
|
HCV-RNA
|
2.0
|
LIU/ mL
|
(−)
|
Ht
| |
%
|
40.4–51.9
|
D-bil
|
0.1
|
mg/dL
|
< 0.4
|
HCV serotype
|
Group2
| |
(−)
|
Plt
|
295
|
×103/μL
|
14.0–37.9
|
AST
|
23
|
U/L
|
10–40
|
HIV Ab
|
(−)
| |
(−)
|
| | | |
ALT
|
19
|
U/L
|
5–45
|
HTLV-1 Ab
|
(−)
| |
(−)
|
Coagulation
|
LDH
|
211
|
U/L
|
120–245
| | | | |
PT
|
12
|
sec
|
10.0–13.0
|
ALP
|
238
|
U/L
|
104–338
|
Tumor Marker
|
PT%
|
99
|
%
|
80.0–120.0
|
γ-GTP
|
104
|
U/L
|
< 79
|
β2MG
|
2.5
|
mg/ L
|
0.9–1.9
|
PT-INR
|
1.01
|
ratio
|
0.90–1.13
|
ChE
|
305
|
U/L
|
245–495
|
sIL-2R
|
1753
|
U/ mL
| |
APTT
|
28
|
sec
|
26.0–38.0
|
CPK
|
53
|
U/L
|
50–230
|
SP-D
|
169.3
|
ng/ mL
|
< 110.0
|
Fib
|
304
|
mg/dL
|
170–410
| | | | | | | | |
- Ab antibody, Ag antigen, sIL-2R soluble IL-2 recepter, β2-MG β2-microglobulin